Beyond clinical markers, gene expression profiling has refined breast cancer classification, with the PAM50 signature identifying five intrinsic subtypes: Luminal A (LumA), Luminal B (LumB), HER2-enriched, Basal-like, and Normal-like [2, 3]. This evidence concerns the gene ERBB2 and breast carcinoma.